Vaccinia Capping Enzyme Fusion Transcript Assembly
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of active vaccinia capping enzyme is challenging due to the insolubility and hydrophobicity of the 97 kDa subunit, leading to low yields and inefficient assembly of the heterodimer, which results in little to no catalytic activity.
Innovation Solution
A vaccinia capping enzyme fusion transcript is designed comprising sequences encoding the D1 and D12 subunits, linked by a flexible or cleavable linker, which is expressed using a yeast expression system such as Pichia pastoris, enabling the production of a catalytically active vaccinia capping enzyme.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the D1 subunit is expressed separately, then the catalytic activities can be achieved, but the insolubility and hydrophobicity of the D1 subunit leads to low yields and inefficient assembly
Solution Approach 1:
The patent combines the D1 and D12 subunit coding sequences into a single fusion transcript, where the D1 subunit is fused to the D12 subunit through a linker sequence. This merging approach ensures that both subunits are produced in equimolar amounts from a single transcription event, eliminating the assembly inefficiencies associated with expressing the hydrophobic D1 subunit separately. The fusion protein is expressed as a single polypeptide chain that subsequently processes into the functional heterodimer.
2Quantity of substance
If the D1 and D12 subunits are expressed separately, then the heterodimer can be formed, but the hydrophobicity of D1 subunit causes insolubility and low yields
Solution Approach 1:
The patent introduces a linker sequence as an intermediary element between the D1 and D12 subunits in the fusion transcript. This linker acts as a mediator that connects the hydrophobic D1 subunit with the D12 subunit, facilitating proper folding and solubility of the fusion protein while maintaining the catalytic activities of D1 and the stimulatory function of D12. The linker prevents aggregation of the hydrophobic D1 subunit by providing a soluble connection to D12.
3Reliability
If equimolar amounts of D1 and D12 are required for activity, then separate expression leads to assembly inefficiency, but fusion expression solves this problem
Solution Approach 1:
The patent merges the coding sequences for D1 and D12 subunits into a single fusion transcript with a defined linker sequence. This merging ensures that both subunits are produced in equimolar amounts from one transcription event, guaranteeing the stoichiometric balance required for catalytic activity. The fusion approach simplifies the expression system by eliminating the need for separate expression vectors and timing coordination, while maintaining reliable production of active enzyme.
Data Source
AI summary
The present disclosure relates, according to some embodiments, to compositions, methods, and/or kits for producing vaccinia capping enzyme. For example, active, heterodimers of vaccinia capping enzyme may be produced as fusions comprising D1 and D12 subunits. Vaccinia capping enzyme fusion proteins may further comprise a linker.